DE69225757D1 - Lyophilische monoklonale antikörperpräparationen - Google Patents

Lyophilische monoklonale antikörperpräparationen

Info

Publication number
DE69225757D1
DE69225757D1 DE69225757T DE69225757T DE69225757D1 DE 69225757 D1 DE69225757 D1 DE 69225757D1 DE 69225757 T DE69225757 T DE 69225757T DE 69225757 T DE69225757 T DE 69225757T DE 69225757 D1 DE69225757 D1 DE 69225757D1
Authority
DE
Germany
Prior art keywords
lyophilic
monoclonal antibody
antibody preparations
preparations
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69225757T
Other languages
English (en)
Other versions
DE69225757T2 (de
Inventor
Tamotsu Fukuda
Yukio Shimazaki
Yasuyuki Kuroiwa
Shiro Takagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12663510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69225757(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Application granted granted Critical
Publication of DE69225757D1 publication Critical patent/DE69225757D1/de
Publication of DE69225757T2 publication Critical patent/DE69225757T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69225757T 1991-03-08 1992-02-28 Lyophilische monoklonale antikörperpräparationen Expired - Fee Related DE69225757T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4343191 1991-03-08
PCT/JP1992/000226 WO1992015331A1 (fr) 1991-03-08 1992-02-28 Preparation lyophilisee d'anticorps monoclonaux

Publications (2)

Publication Number Publication Date
DE69225757D1 true DE69225757D1 (de) 1998-07-09
DE69225757T2 DE69225757T2 (de) 1998-12-03

Family

ID=12663510

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69232617T Expired - Fee Related DE69232617T2 (de) 1991-03-08 1992-02-28 Gefriergetrocknete Zubereitung, die einen monoklonalen Antikörper enthält
DE69225757T Expired - Fee Related DE69225757T2 (de) 1991-03-08 1992-02-28 Lyophilische monoklonale antikörperpräparationen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69232617T Expired - Fee Related DE69232617T2 (de) 1991-03-08 1992-02-28 Gefriergetrocknete Zubereitung, die einen monoklonalen Antikörper enthält

Country Status (10)

Country Link
US (1) US5908826A (de)
EP (2) EP0531539B1 (de)
JP (1) JPH0565233A (de)
AU (1) AU645187B2 (de)
CA (1) CA2082169A1 (de)
DE (2) DE69232617T2 (de)
DK (2) DK0531539T3 (de)
FI (1) FI924982A (de)
NO (1) NO924279D0 (de)
WO (1) WO1992015331A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
GB9122820D0 (en) * 1991-10-28 1991-12-11 Wellcome Found Stabilised antibodies
CN102416176A (zh) * 1995-07-27 2012-04-18 基因技术股份有限公司 稳定等渗的冻干蛋白质制剂
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
JP2014148555A (ja) * 1995-07-27 2014-08-21 Genentech Inc タンパク質の処方
JP3624543B2 (ja) * 1996-05-02 2005-03-02 東ソー株式会社 免疫反応試薬及びその製造方法
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
AU2444899A (en) * 1998-01-22 1999-08-09 Astrazeneca Ab Pharmaceutical formulation comprising an antibody and a citrate buffer
US6750330B1 (en) * 1998-05-14 2004-06-15 Ashley Davis Lyophilized tubulins
US20030124119A1 (en) * 1999-12-28 2003-07-03 Tadao Yamazaki Stable antibody compositions and injection preparations
JP5490972B2 (ja) * 2000-08-04 2014-05-14 中外製薬株式会社 タンパク質注射製剤
CA2423227C (en) 2000-10-12 2011-11-29 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
GB0113179D0 (en) * 2001-05-31 2001-07-25 Novartis Ag Organic compounds
ES2338218T3 (es) * 2001-07-25 2010-05-05 Facet Biotech Corporation Formulacion farmacologica liofilizada estable de anticuerpos igg daclizumab.
US20040002451A1 (en) 2002-06-20 2004-01-01 Bruce Kerwin Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
ES2609010T3 (es) 2003-04-04 2017-04-18 Genentech, Inc. Formulaciones de anticuerpos y de proteínas a concentración elevada
TW200510532A (en) 2003-07-15 2005-03-16 Chugai Pharmaceutical Co Ltd IgM production by transformed cell and method of quantifying the same
WO2005035573A1 (ja) 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha タンパク質溶液の安定化方法
EP1688432B1 (de) * 2003-10-09 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Stabilisierte lösung mit hoher igm-konzentration
ES2553987T3 (es) * 2003-12-25 2015-12-15 Kyowa Hakko Kirin Co., Ltd. Preparación farmacéutica de base acuosa estable que contiene anticuerpo
EP1888637A2 (de) * 2005-05-19 2008-02-20 Amgen Inc. Zusammensetzungen und verfahren zur erhöhung der stabilität von antikörpern
MX2007015476A (es) 2005-06-14 2008-02-25 Amgen Inc Formulaciones de proteina autoamortiguadoras.
WO2007074880A1 (ja) * 2005-12-28 2007-07-05 Chugai Seiyaku Kabushiki Kaisha 抗体含有安定化製剤
AR059066A1 (es) 2006-01-27 2008-03-12 Amgen Inc Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
CA2665567C (en) * 2006-10-06 2012-07-03 Amgen Inc. Stable formulations
EP2094247B1 (de) * 2006-10-20 2022-06-29 Amgen Inc. Stabile polypeptid-formulierungen
JP2010522208A (ja) * 2007-03-22 2010-07-01 イムクローン・リミテッド・ライアビリティ・カンパニー 安定な抗体処方物
JP5322405B2 (ja) * 2007-06-07 2013-10-23 小林製薬株式会社 タンパク質含有組成物
CN102414221A (zh) 2009-03-06 2012-04-11 健泰科生物技术公司 抗体配制剂
NZ702494A (en) 2010-03-01 2016-09-30 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
WO2012028683A1 (en) 2010-09-02 2012-03-08 Novartis Ag Antibody gel system for sustained drug delivery
TWI604851B (zh) 2010-11-05 2017-11-11 諾華公司 Ｉｌ－１７抗體用於製備治療強直性脊椎炎之藥物之用途
HUE029457T2 (en) 2010-11-11 2017-02-28 Abbvie Biotechnology Ltd Liquid formulations containing a high concentration of ANTI-TNF-alpha antibody
JP2012158615A (ja) * 2012-05-28 2012-08-23 Kobayashi Pharmaceutical Co Ltd 還元糖によるタンパク質変性を抑制する方法
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
WO2015185998A2 (en) 2014-04-11 2015-12-10 Acerta Pharma B.V. Methods of blocking the cxcr-4/sdf-1 signaling pathway with inhibitors of bone marrow x kinase
US9937171B2 (en) 2014-04-11 2018-04-10 Acerta Pharma B.V. Methods of blocking the CXCR-4/SDF-1 signaling pathway with inhibitors of bruton's tyrosine kinase
TW201618774A (zh) 2014-08-11 2016-06-01 艾森塔製藥公司 使用ｂｔｋ抑制劑透過調變腫瘤微環境來治療實體腫瘤及其他疾病之方法
WO2016055982A1 (en) 2014-10-10 2016-04-14 Acerta Pharma B.V. Quinoline and quinazoline compounds
WO2016087994A1 (en) 2014-12-05 2016-06-09 Acerta Pharma B.V. Btk inhibitors to treat solid tumors through modulation of the tumor microenvironment
PT3334747T (pt) 2015-08-13 2023-12-12 Amgen Inc Formulação de gonadotrofina líquida estável
EP3865485A1 (de) 2015-11-06 2021-08-18 Acerta Pharma B.V. Imidazopyrazinhemmer der bruton-tyrosinkinase

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2149304A (en) * 1936-04-20 1939-03-07 Sharp & Dohme Inc Lyophilic biologically active substances
SU700132A1 (ru) * 1978-06-30 1979-11-30 Томский Ордена Трудового Красного Знамени Научно-Исследовательский Институт Вакцин И Сывороток Способ получени сухого препарата иммуноглобулина
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
JPS58167518A (ja) * 1982-03-29 1983-10-03 Nippon Sekijiyuujishiya ゼラチン誘導体添加静注用人免疫グロブリンの製造法
JPS6035263A (ja) * 1983-08-05 1985-02-23 Wako Pure Chem Ind Ltd 不溶性担体に固定化された免疫活性物質の安定化法及び該物質を構成単位として含む生理活性物質測定用試薬
JPS60146833A (ja) * 1984-01-10 1985-08-02 Green Cross Corp:The モノクロ−ナル抗体製剤
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4650772A (en) * 1984-08-09 1987-03-17 Abbott Laboratories Monoclonal antibody stabilization
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61176532A (ja) * 1985-01-30 1986-08-08 Green Cross Corp:The プラスミノ−ゲンアクチベ−タ−前駆体の安定化方法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0825903B2 (ja) * 1985-05-16 1996-03-13 株式会社ミドリ十字 γ―グロブリン含有水溶液
JPS6178731A (ja) * 1985-05-20 1986-04-22 Green Cross Corp:The 加熱処理免疫グロブリン製剤
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
JPS6388197A (ja) * 1986-09-30 1988-04-19 Tosoh Corp モノクロナル抗体の安定化方法
EP0327648B1 (de) * 1986-12-15 1993-06-09 MITSUI TOATSU CHEMICALS, Inc. Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten
ES2045027T3 (es) * 1987-08-10 1994-01-16 Miles Inc Igm purificadas.
WO1989011298A1 (en) * 1988-05-27 1989-11-30 Centocor, Inc. Formulation for antibody reagents
EP0465513A1 (de) * 1989-03-27 1992-01-15 Centocor, Inc. Formulierungen zur stabilisierung von igm-antikörpern
JPH0384461A (ja) * 1989-08-28 1991-04-10 Green Cross Corp:The 免疫学的凝集反応試薬及びその製法
JPH0911350A (ja) * 1995-06-30 1997-01-14 Olympus Optical Co Ltd エネルギー硬化型樹脂を用いた光学素子の製造方法

Also Published As

Publication number Publication date
JPH0565233A (ja) 1993-03-19
FI924982A0 (fi) 1992-11-04
DE69225757T2 (de) 1998-12-03
US5908826A (en) 1999-06-01
EP0841067A1 (de) 1998-05-13
DE69232617D1 (de) 2002-06-27
NO924279L (no) 1992-11-06
DK0841067T3 (da) 2002-07-15
NO924279D0 (no) 1992-11-06
CA2082169A1 (en) 1992-09-09
DE69232617T2 (de) 2002-10-31
WO1992015331A1 (fr) 1992-09-17
EP0531539B1 (de) 1998-06-03
EP0531539A4 (de) 1995-04-05
AU645187B2 (en) 1994-01-06
DK0531539T3 (da) 1998-10-12
EP0841067B1 (de) 2002-05-22
AU1337592A (en) 1992-10-06
FI924982A (fi) 1992-11-04
EP0531539A1 (de) 1993-03-17

Similar Documents

Publication Publication Date Title
DE69225757D1 (de) Lyophilische monoklonale antikörperpräparationen
DK666389D0 (da) Monoklonalt antistof
DE69232604D1 (de) Antikörperkonstrukte
DE68914244D1 (de) Monoklonaler Antikörper.
CY2006001I2 (el) Ανθρωποποιημενο heregulin αντισωμα
DK145493D0 (da) Antistof
DK19991D0 (da) Proteinpraeparationer
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
EP0580859A4 (en) Anti-eda monoclonal antibody
NO920523L (no) Ige-reseptor-antistoff
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
EP0506523A3 (en) Monoclonal antibodies
FI934588A (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
DK717888A (da) Monoklonale antistoffer
DK474189A (da) Monoklonalt antistof
NO890116D0 (no) Monoklonale antistoffer.
DK413389D0 (da) Monoklonale antistoffer
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
DE69023717D1 (de) Monoklonaler Antikörper.
DK370089A (da) Anti-urokinase monoklonale antistoffer
NO924803D0 (no) Tumor-relatert monoklonalt antistoff 88bv59
DE69020315D1 (de) Monoklonaler antikörper gegen c-reaktives protein.
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
DE69324928D1 (de) Monoklonaler antikörper
DK149591D0 (da) Proteinpraeparat

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MITSUI CHEMICALS, INC., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee